Welcome to our dedicated page for Caring Brands SEC filings (Ticker: CABR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Caring Brands, Inc. filings document the company's securities registration, capital structure, governance changes, and material events as a Nasdaq-listed wellness consumer products issuer. Its S-1 registration materials describe common stock offerings, business disclosures, risk factors, financial statements, and the company's OTC and cosmetic product focus.
Recent 8-K filings cover Nasdaq continued-listing compliance, amendments to shareholder-meeting quorum requirements, executive finance-function changes, and financing transactions involving Series A Convertible Preferred Stock, common warrants, and insider share redemptions. Other event disclosures record patent-related updates for the Hair Enzyme Booster product and related intellectual property matters.
Caring Brands, Inc. Chief Executive Officer Dr. Glynn Wilson reported a disposition of 1,500,000 shares of common stock back to the company. The shares were redeemed at approximately $0.50 per share under a Share Redemption Agreement signed on March 19, 2026.
After this issuer redemption, Dr. Wilson beneficially owns 500,000 shares of common stock and 172,592 restricted stock units, none of which have vested. He therefore continues to hold a meaningful equity stake that aligns his interests with other shareholders.
Caring Brands, Inc. director John Brian reported a large share redemption transaction. He disposed of 1,250,000 shares of Common Stock at approximately $1.00 per share in a redemption by the company under a Share Redemption Agreement signed on March 19, 2026. After this disposition to the issuer, he directly holds 750,000 shares of Caring Brands common stock.
Caring Brands, Inc. entered into a $3.6 million private investment in public equity, issuing 3,789.74 shares of Series A Convertible Preferred Stock at $950 per share with a stated value of $1,000 and an 8% dividend. The preferred stock is convertible into common shares at $0.40 and is paired with 9,473,685 common warrants, also exercisable at $0.40 for five years, all subject to beneficial ownership limits and a 19.99% cap without shareholder approval.
The company plans to use $3.075 million of the proceeds to repurchase 6,250,000 common shares from insiders, reducing common shares outstanding from 14,761,925 to 8,511,925, with the balance for general corporate and working capital needs. The investor also obtained an option to invest up to an additional $4.0 million on similar terms and received a 12‑month right of first refusal on future financings, while the company agreed to register the resale of the underlying shares.
Caring Brands, Inc. reported that it has been issued two new United States patents. These patents cover proprietary methods and compositions that enhance enzymatic activity in hair follicles. Management explains that this intellectual property further strengthens protection around its Hair Enzyme Booster product and related technologies, potentially reinforcing its competitive position in hair-focused treatments.
Caring Brands, Inc. reported that its Chief Financial Officer, Tyler Moore, resigned from his position effective after notifying the company on January 5, 2026. The company states that his resignation was not due to any disagreement regarding its operations, policies, or practices, which signals this is characterized as an orderly leadership change rather than a dispute.
Caring Brands has begun a search to identify a new Chief Financial Officer and expects to appoint a successor in the near term. Until a replacement is named, the company plans to handle its financial and reporting responsibilities through its existing management team, indicating continuity of core finance functions during the transition.
Caring Brands, Inc. reported that director Hector W. Alila received a grant of stock options to purchase 25,000 shares of common stock at an exercise price of $1.13 per share on December 11, 2025.
The options vested immediately on the grant date and are scheduled to expire on December 11, 2030, leaving 25,000 derivative securities beneficially owned directly by the reporting person after the transaction. The grant was approved by the company’s board of directors under its equity incentive plan following a recommendation from the compensation committee.
Caring Brands, Inc. reported an insider equity award involving a director who is also a 10% owner. On December 11, 2025, the board, following a recommendation from the compensation committee, approved a grant of 100,000 stock options under the company’s equity incentive plan, with an exercise price of $1.243 per share and no cost to acquire the options themselves.
The options are scheduled to fully vest on June 11, 2026, provided the reporting person continues to serve the company, and they are set to expire on December 11, 2030. After this transaction, the reporting person beneficially owns 100,000 stock options and also holds 2,000,000 shares of Caring Brands common stock.
Caring Brands, Inc. director Christopher Melton reported receiving a stock option grant from the company. On December 11, 2025, the board of directors, following a recommendation from the compensation committee, approved an option for Melton to buy 25,000 shares of common stock at an exercise price of $1.13 per share under the company’s equity incentive plan.
The options vested immediately on December 11, 2025 and expire on December 11, 2030. Following this grant, Melton beneficially owns 25,000 stock options directly.
Caring Brands, Inc. director Christopher Matthew Galeta received a stock option grant on December 11, 2025 under the company’s equity incentive plan. The award covers 25,000 stock options with an exercise price of $1.13 per share, giving him the right to buy 25,000 shares of common stock at that price.
The options were approved by the Board of Directors at the recommendation of the Compensation Committee and vest immediately as of December 11, 2025. After this grant, Galeta beneficially owns 25,000 derivative securities in the form of these stock options, which expire on December 11, 2030.
Caring Brands, Inc. disclosed that its Chief Executive Officer, director, and 10% owner, Dr. Glynn Wilson, received two restricted stock unit (RSU) grants of common stock on December 11, 2025 under the company’s equity incentive plan. The first award covers 126,720 RSUs that fully vest on June 11, 2026, and the second covers 45,872 RSUs that fully vest on December 11, 2026, in each case conditioned on Dr. Wilson’s continued service with the company.
Both grants are shown at a price of $0 per share, reflecting equity compensation rather than an open‑market purchase. Following these awards, Dr. Wilson is reported as beneficially owning 2,172,592 shares of Caring Brands common stock, which includes his prior ownership of 2,000,000 shares.